Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EDV-2209 by Edvince for Subarachnoid Hemorrhage: Likelihood of Approval
EDV-2209 is under clinical development by Edvince and currently in Phase II for Subarachnoid Hemorrhage. According to GlobalData, Phase II...